StockMacro
Menu

Cigna

$270.90 -3.5% in 6 monthsMarket cap $71.4B

CI on XNYS, Financials, The Cigna Group, job postings

Measures activity, not value. Not investment advice.

Shares fell 11% in one month while quarterly revenue rose 5.6% to $73.7B.

  • WatchRevenue up 6.8% over 12 months, but profit up only 1.3%

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

Industry
Hospital & medical service plans (Financials)
Employees
67,700
Website
thecignagroup.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $73.7B, net income $1.4B.
Quarter to 31 Dec 2021: revenue $45.7B, net income $1.1BQuarter to 31 Dec 2021: revenue $45.7B, net income $1.1BQuarter to 31 Mar 2022: revenue $44.0B, net income $1.2BQuarter to 31 Mar 2022: revenue $44.0B, net income $1.2BQuarter to 30 Jun 2022: revenue $45.5B, net income $1.6BQuarter to 30 Jun 2022: revenue $45.5B, net income $1.6BQuarter to 30 Sep 2022: revenue $45.3B, net income $2.8BQuarter to 30 Sep 2022: revenue $45.3B, net income $2.8BQuarter to 31 Dec 2022: revenue $45.8B, net income $1.2BQuarter to 31 Dec 2022: revenue $45.8B, net income $1.2BQuarter to 31 Mar 2023: revenue $46.5B, net income $1.3BQuarter to 31 Mar 2023: revenue $46.5B, net income $1.3BQuarter to 30 Jun 2023: revenue $48.6B, net income $1.5BQuarter to 30 Jun 2023: revenue $48.6B, net income $1.5BQuarter to 30 Sep 2023: revenue $49.0B, net income $1.4BQuarter to 30 Sep 2023: revenue $49.0B, net income $1.4BQuarter to 31 Dec 2023: revenue $51.1B, net income –Quarter to 31 Mar 2024: revenue $57.3B, net income -$212.0MQuarter to 31 Mar 2024: revenue $57.3B, net income -$212.0MQuarter to 30 Jun 2024: revenue $60.5B, net income $1.6BQuarter to 30 Jun 2024: revenue $60.5B, net income $1.6BQuarter to 30 Sep 2024: revenue $63.7B, net income $825.0MQuarter to 30 Sep 2024: revenue $63.7B, net income $825.0MQuarter to 31 Dec 2024: revenue $65.6B, net income –Quarter to 31 Mar 2025: revenue $65.5B, net income $1.4BQuarter to 31 Mar 2025: revenue $65.5B, net income $1.4BQuarter to 30 Jun 2025: revenue $67.2B, net income $1.6BQuarter to 30 Jun 2025: revenue $67.2B, net income $1.6BQuarter to 30 Sep 2025: revenue $69.7B, net income $2.0BQuarter to 30 Sep 2025: revenue $69.7B, net income $2.0BQuarter to 31 Dec 2025: revenue $72.5B, net income $1.2BQuarter to 31 Dec 2025: revenue $72.5B, net income $1.2BQuarter to 31 Mar 2026: revenue $68.5B, net income $1.7BQuarter to 31 Mar 2026: revenue $68.5B, net income $1.7BQuarter to 30 Jun 2026: revenue $71.7B, net income $1.7BQuarter to 30 Jun 2026: revenue $71.7B, net income $1.7BQuarter to 30 Sep 2026: revenue $73.7B, net income $1.4BQuarter to 30 Sep 2026: revenue $73.7B, net income $1.4B
31 Dec 2021RevenueNet incomeNet losstallest bar $73.7B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$73.7B$1.4B
30 Jun 2026$71.7B$1.7B
31 Mar 2026$68.5B$1.7B
31 Dec 2025$72.5B$1.2B
30 Sep 2025$69.7B$2.0B
30 Jun 2025$67.2B$1.6B
31 Mar 2025$65.5B$1.4B
31 Dec 2024$65.6B–
30 Sep 2024$63.7B$825.0M
30 Jun 2024$60.5B$1.6B
31 Mar 2024$57.3B-$212.0M
31 Dec 2023$51.1B–
30 Sep 2023$49.0B$1.4B
30 Jun 2023$48.6B$1.5B
31 Mar 2023$46.5B$1.3B
31 Dec 2022$45.8B$1.2B
30 Sep 2022$45.3B$2.8B
30 Jun 2022$45.5B$1.6B
31 Mar 2022$44.0B$1.2B
31 Dec 2021$45.7B$1.1B
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $286.3B $268.1B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.8% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $6.0B $5.9B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $22.68 $22.55
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 20.7% 23.1% 20.7%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 3.4% 3.4% 1.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 2.1% 2.2% 1.7%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 14.1% 9.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. – –
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. –
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $164.64
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 11.9 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.25 0.42
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. –
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.6 2.7
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 2.2% 2.3%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small. Cash, debt and EV/Sales are not shown for banks, insurers and investment companies.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
CignaCI (this company) $71.4B11.90.25+6.8%2.1%
Elevance HealthELV $85.2B16.60.42+3.6%2.5%
HumanaHUM $46.8B37.60.30+22%0.8%
CenteneCNC $31.6B21.6–––
UnitedhealthUNH $304.5B19.20.68+3.3%3.5%
Molina HealthcareMOH $10.4Bloss0.23-0.9%-0.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$175K

bought $0, sold $175K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-3.2%

1,612 13F filers vs 1,665

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

88%

232.5M shares held by 13F filers (30 Sep 2026) of 263.5M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.4%

6.2M shares sold short (30 Oct 2026) of 263.5M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.2

6.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-7.8%

6.8M shares sold short in the report before, 6.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

33%

33% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 46%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

505

Tracked since 22 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 22 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+5.6%

$73.7B vs $69.7B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$12.0M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

58

58 articles in the last 7 days; its usual week has 7 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.3×

58 articles in the last 7 days; its usual week has 7.

Price $270.90 on 20 Nov 2026, +0.5% over 12 months (12-month range $258.08 to $315.88)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $66.8M in the last 12 months (the 12 months before: -$22.8M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 32 published in the last 12 months, +433% on the 12 months before.
Revenue per quarter. Revenue $73.7B in the latest quarter, +5.6% on a year earlier.
Institutional holders (13F filers). 1,612 13F filers reported holding it in the latest 13F quarter, +4.8% on a year earlier.
Lobbying spend. Lobbying spend: $12.0M published in the last 12 months, +20% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: capital spending per quarter, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 Oct 20268-K and other filingsDirector or officer change
9 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Apr 2026Sharp changeShort interest spike: short interest spike, 6.8M vs usual 3.5M (2026-03-31); 2.0x the same period a year earlier
13 Apr 2026Lobbying filingnew lobbying registration (RED+BLUE STRATEGIES)
31 Mar 2026Sharp changeShort interest spike: short interest spike, 6.4M vs usual 3.5M (2026-03-13); 1.7x the same period a year earlier
3 Mar 20268-K and other filingsDirector or officer change
3 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Oct 20258-K and other filingsDirector or officer change
20 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jun 20258-K and other filingsDirector or officer change
15 May 2025Sharp changeMany funds opening a new position: many funds opening a new position, 165 vs usual 104 (2025-03-31); 1.2x the same period a year earlier
28 Apr 20258-K and other filingsA major agreement ended
28 Apr 20258-K and other filingsDirector or officer change
18 Apr 20258-K and other filingsDirector or officer change
30 Mar 2025Lobbying filingnew lobbying registration (BELLWETHER GOVERNMENT AFFAIRS LLC)
13 Mar 20258-K and other filingsDirector or officer change
13 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Nov 2024Sharp changeQuarterly revenue change: quarterly revenue change, 63.7B vs usual 48.8B (2024-09-30); 1.3x the same period a year earlier
20 Jun 20248-K and other filingsDirector or officer change
20 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Apr 2024Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.2M (2024-03-28); 1.8x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 5.8M vs usual 3.1M (2024-03-15); 2.1x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 6.5M vs usual 3.1M (2024-02-29); 2.4x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 7.3M vs usual 3.1M (2024-02-15); 3.1x the same period a year earlier
19 Jan 20248-K and other filingsDirector or officer change
17 Jan 20248-K and other filingsDirector or officer change
17 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Sep 20238-K and other filingsDirector or officer change
15 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Jul 2023Lobbying filinglobbying engagement terminated (THE NICKLES GROUP, LLC)
17 Jul 2023Lobbying filingnew lobbying registration (ATLAS CROSSING LLC)
1 May 20238-K and other filingsDirector or officer change
1 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Aug 2022Sharp changeShort interest spike: short interest spike, 6.9M vs usual 3.8M (2022-07-29); 1.8x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 7.9M vs usual 3.8M (2022-07-15); 2.1x the same period a year earlier
Insider net buying (open market)
Month from 1 Jan 2022: -$1.1M published
Month from 1 Mar 2022: -$3.0M published
Month from 1 Apr 2022: -$32.3M published
Month from 1 May 2022: -$13.8M published
Month from 1 Jul 2022: -$6.9M published
Month from 1 Aug 2022: -$2.4M published
Month from 1 Sep 2022: -$2.4M published
Month from 1 Oct 2022: -$1.3M published
Month from 1 Dec 2022: -$6.6M published
Month from 1 Mar 2023: -$10.5M published
Month from 1 May 2023: -$192K published
Month from 1 Jul 2023: -$4.5M published
Month from 1 Aug 2023: -$6.4M published
Month from 1 Sep 2023: -$1.1M published
Month from 1 Feb 2024: -$25.8M published
Month from 1 Mar 2024: -$30.0M published
Month from 1 May 2024: -$5.8M published
Month from 1 Jun 2024: -$2.2M published
Month from 1 Aug 2024: -$10.5M published
Month from 1 Mar 2025: -$13.6M published
Month from 1 Aug 2025: -$8.6M published
Month from 1 Oct 2025: -$1.6M published
Month from 1 Nov 2025: $1.0M published
Month from 1 Mar 2026: -$1.2M published
Month from 1 May 2026: -$59.1M published
Month from 1 Jun 2026: -$268K published
Month from 1 Aug 2026: -$6.1M published
Month from 1 Sep 2026: -$175K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 36 published
Quarter from 1 Apr 2022: 8 published
Quarter from 1 Jul 2022: 11 published
Quarter from 1 Oct 2022: 5 published
Quarter from 1 Jan 2023: 3 published
Quarter from 1 Apr 2023: 3 published
Quarter from 1 Jul 2023: 4 published
Quarter from 1 Apr 2024: 1 published
Quarter from 1 Jul 2024: 4 published
Quarter from 1 Oct 2024: 3 published
Quarter from 1 Jan 2025: 3 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Apr 2026: 2 published
Quarter from 1 Jul 2026: 5 published
Quarter from 1 Oct 2026: 24 published
Revenue per quarter
Quarter ended 31 Dec 2021: $45.7B, +9.5% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $44.0B, +7.4% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $45.5B, +5.4% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $45.3B, +2.2% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $45.8B, +0.1% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $46.5B, +5.7% on a year earlier; public on 6 May 2023
Quarter ended 30 Jun 2023: $48.6B, +6.8% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $49.0B, +8.3% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $51.1B, +12% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $57.3B, +23% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $60.5B, +25% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $63.7B, +30% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $65.6B, +28% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $65.5B, +14% on a year earlier; public on 3 May 2025
Quarter ended 30 Jun 2025: $67.2B, +11% on a year earlier; public on 1 Aug 2025
Quarter ended 30 Sep 2025: $69.7B, +9.5% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $72.5B, +10% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $68.5B, +4.6% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $71.7B, +6.7% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $73.7B, +5.6% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 1,182; public on 14 Feb 2022
31 Mar 2022 report: 1,272; public on 16 May 2022
30 Jun 2022 report: 1,330; public on 15 Aug 2022
30 Sep 2022 report: 1,349; public on 14 Nov 2022
31 Dec 2022 report: 1,411; public on 14 Feb 2023
31 Mar 2023 report: 1,379; public on 15 May 2023
30 Jun 2023 report: 1,364; public on 14 Aug 2023
30 Sep 2023 report: 1,376; public on 14 Nov 2023
31 Dec 2023 report: 1,506; public on 14 Feb 2024
31 Mar 2024 report: 1,569; public on 15 May 2024
30 Jun 2024 report: 1,568; public on 14 Aug 2024
30 Sep 2024 report: 1,595; public on 14 Nov 2024
31 Dec 2024 report: 1,551; public on 14 Feb 2025
31 Mar 2025 report: 1,611; public on 15 May 2025
30 Jun 2025 report: 1,647; public on 14 Aug 2025
30 Sep 2025 report: 1,538; public on 14 Nov 2025
31 Dec 2025 report: 1,586; public on 17 Feb 2026
31 Mar 2026 report: 1,615; public on 15 May 2026
30 Jun 2026 report: 1,665; public on 14 Aug 2026
30 Sep 2026 report: 1,612; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $3.7M published
Quarter from 1 Apr 2022: $4.0M published
Quarter from 1 Jul 2022: $1.3M published
Quarter from 1 Oct 2022: $3.3M published
Quarter from 1 Jan 2023: $1.4M published
Quarter from 1 Apr 2023: $5.6M published
Quarter from 1 Jul 2023: $2.1M published
Quarter from 1 Oct 2023: $2.0M published
Quarter from 1 Jan 2024: $2.3M published
Quarter from 1 Apr 2024: $3.3M published
Quarter from 1 Jul 2024: $2.6M published
Quarter from 1 Oct 2024: $2.1M published
Quarter from 1 Jan 2025: $1.8M published
Quarter from 1 Apr 2025: $3.9M published
Quarter from 1 Jul 2025: $2.4M published
Quarter from 1 Oct 2025: $1.9M published
Quarter from 1 Jan 2026: $2.2M published
Quarter from 1 Apr 2026: $4.0M published
Quarter from 1 Jul 2026: $2.7M published
Quarter from 1 Oct 2026: $3.2M published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is lobbying spend reported (quarter) at $3.2M (30 Sep 2026), 1.4× its normal reading; higher than 91% of its own history.
  • Insider net buying (open market): Insiders sold a net $66.8M in the last 12 months (the 12 months before: -$22.8M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 32 published in the last 12 months, +433% on the 12 months before.
  • Revenue per quarter: Revenue $73.7B in the latest quarter, +5.6% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $175K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
8 Sep 2026Everett NevilleSee RemarksSellplanned in advance (10b5-1)617$284.05$175KForm 4
20 Aug 2026Nicole S JonesSee RemarksSellplanned in advance (10b5-1)2,677$279.61$749KForm 4
6 Aug 2026Nicole S JonesSee RemarksSellplanned in advance (10b5-1); after exercising options19,436$276.27$5.4MForm 4
16 Jun 2026Jamie G KatesChief Accounting OfficerSellafter exercising options899$298.61$268KForm 4
14 May 2026David CordaniChairman & CEOSellplanned in advance (10b5-1); after exercising options201,878$292.82$59.1MForm 4
3 Mar 2026Nicole S JonesSee RemarksSellplanned in advance (10b5-1)2,307$288.91$667KForm 4
3 Mar 2026Everett NevilleSee RemarksSellplanned in advance (10b5-1)1,719$288.91$497KForm 4
3 Nov 2025David CordaniChairman & CEOBuy4,134$241.88$1.0MForm 4

1,612 institutions reported shares at the end of Q3 2026, 88% of the shares outstanding; 88 opened a position, 138 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.24.1M9.15%$6.6B+675K+2.9%
Vanguard Capital Management LLC17.3M6.56%$4.7B+15K+0.1%
State Street Corp13.0M4.92%$3.5B+277K+2.2%
Dodge & Cox12.3M4.65%$3.3B+82K+0.7%
Sanders Capital, LLC10.1M3.83%$2.7B-47K-0.5%
Massachusetts Financial Services Co9.7M3.70%$2.7B-703K-6.7%
Geode Capital Management, LLC6.8M2.59%$1.8B+549K+8.8%
FMR LLC (Fidelity)6.8M2.59%$1.9B-1.2M-15%
Vanguard Portfolio Management LLC6.3M2.39%$1.7B+79K+1.3%
JPMorgan Chase & Co5.1M1.92%$1.4B-143K-2.7%

Company events

All 35 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
9 Oct 2026Director or officer change8-K
3 Mar 2026Director or officer change8-K
20 Oct 2025Director or officer change8-K
4 Sep 2025Signed a major agreementSame filing: took on new debt8-K
2 Jun 2025Director or officer change8-K
28 Apr 2025Director or officer change; Signed a major agreement; A major agreement endedSame filing: took on new debt, shareholder vote results8-K
18 Apr 2025Director or officer change8-K
13 Mar 2025Director or officer change8-K

505 open postings; careers site tracked since 22 Nov 2026. Most in Software engineering 7%, Sales & business development 5%, Operations & administration 5%, Data & analytics 4%.

PostedJobLocation
22 Nov 2026or earlierAccount Management (IC) AssociateMadrid, Spain
22 Nov 2026or earlierProvider Inquiries Representative PT / FR / DEU / ITANot stated
22 Nov 2026or earlierSoftware Engineering Senior Advisor - HIH - EvernorthSoftware engineeringHyderabad, India
22 Nov 2026or earlierManaging Director, Head of PhilippinesNot stated
22 Nov 2026or earlierClaims SupervisorBengaluru, India
22 Nov 2026or earlierAgile Product Management Associate Advisor - HIH - EvernorthProduct managementHyderabad, India
22 Nov 2026or earlierCustomer Service SupervisorCustomer success & supportRiyadh, Saudi Arabia
22 Nov 2026or earlierSenior Data Engineer – Data Mapping & IntegrationData & analyticsBengaluru, India

Reported lobbying spend: $3.2M in Q3 2026, $2.7M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2026NewRed+Blue Strategiesfor The Cigna GroupIssues related to pharmacy benefit management services, pharmacy, specialty pharmacy, and individual and group health insurance markets.Health issuesFiling
17 Mar 2025NewBellwether Government Affairs LLCfor The Cigna Group And SubsidiariesStrategic and policy advice on issues related to federal tax and health care issuesHealth issues, TaxationFiling
30 Jun 2023EndedThe Nickles Group, LLCfor Cigna CorporationMonitored the implementation of H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to health care. Monitored issues related to mental health. Monitored issues related to insulin. Issues related to pharmacy benefit transparency. Issues related to prior authorization, including Cente; Issues related to Medicare Advantage plans, including CMS regulations. Monitored issues related to Improving Seniors Timely Access to Care Act. Monitored issues related to Pharmacy Direct and Indirect Remuneration.; Monitored issues related to corporate taxes.Health issues, Medicare/Medicaid, TaxationFiling
16 Jun 2023NewAtlas Crossing LLCfor The Cigna Group And SubsidiariesIssues related to H.R. 3799 the Custom Health Option and Individual Care Expense Arrangement Act (CHOICE) Act.Health issuesFiling
1 May 2021EndedBose Public Affairs Groupfor Cigna CorporationIssues related to health care policyHealth issuesFiling
1 Apr 2021NewTiber Creek Groupfor Cigna Corporation And SubsidiariesProposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.Medicare/MedicaidFiling
31 Mar 2021EndedTiber Creekfor Cigna CorporationProposals that impact Medicare Part D and ongoing implementation of payment and regulatory issues for the Medicare Advantage program.; Issues impacting insurance coverage, prescription drugs and the federal COVID response in the American Rescue Plan Act of 2021 (PL 117-2).Medicare/Medicaid, Health issuesFiling
1 Oct 2020EndedEnvision Strategy, LLCfor CignaNot statedFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Mar 2017. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Mar 2017Express ScriptsFranklin Lakes, NJ6621 Apr 2017Notice

The 5 newest of 476 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

5 Mar 2019confirmed

Confirmed across sources Institutional holdings and Filings + Financials

Cigna (CI): saw 323 13F filers open a new position in the quarter ended 31 Dec 2018, 3.4× the same quarter last year, while it reported revenue of $14.3B for the quarter ended 31 Dec 2018, 1.3× the same quarter last year. Two unrelated kinds of activity within 14 days.

  • Institutional holdings: Many funds opening a new position, became public on 14 Feb 2019
  • Financials: Quarterly revenue change, became public on 5 Mar 2019
2016-12-31: 522017-03-31: 872017-06-30: 692017-09-30: 532017-12-31: 942018-03-31: 1202018-06-30: 722018-09-30: 1092018-12-31: 323
The quarter ended 31 Dec 2018 against the 8 quarters before it. this quarterearliernormal: 79.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Feb 2019

Cigna saw 323 13F filers open a new position in the quarter ended 31 Dec 2018, 3.4× the same quarter last year.

This period
323 (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
79.5
Typical spread (median absolute deviation)
20.5
How far from its usual level
+8.0
Same quarter last year
94
History used
1,918 days
2016-12-31: 522017-03-31: 872017-06-30: 692017-09-30: 532017-12-31: 942018-03-31: 1202018-06-30: 722018-09-30: 1092018-12-31: 323
the quarter ended 31 Dec 20188 earlier quartersnormal: 79.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Financials: Quarterly revenue change became public on 5 Mar 2019

Cigna reported revenue of $14.3B for the quarter ended 31 Dec 2018, 1.3× the same quarter last year.

This period
$14.3B (the quarter ended 31 Dec 2018)
Normal quarter (median of 7 earlier)
$10.6B
Typical spread (median absolute deviation)
$260.0M
How far from its usual level
+3.4
Same quarter last year
$10.6B
History used
640 days
2017-03-31: $10.4B2017-06-30: $10.4B2017-09-30: $10.4B2017-12-31: $10.6B2018-03-31: $11.4B2018-06-30: $11.5B2018-09-30: $11.5B2018-12-31: $14.3B
the quarter ended 31 Dec 20187 earlier quartersnormal: $10.6B

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 9 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 9 Oct 2026Filings record

    Director or officer change

  3. 13 Apr 2026Lobbying record

    THE CIGNA GROUP: new lobbying registration (RED+BLUE STRATEGIES) (dated 1 Apr 2026)

  4. 11 Apr 2026Short interest and volume change

    had 6.8M shares sold short in the 31 Mar 2026 report, 2.0× the same report last year.

    Same report last year: 3.4M; its normal report is 3.5M.

    See the evidence
    This period
    6.8M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    543K
    How far from its usual level
    +4.1
    Same report last year
    3.4M
    History used
    3,014 days
    2025-03-31: 3.4M2025-04-15: 3.4M2025-04-30: 3.5M2025-05-15: 3.2M2025-05-30: 2.7M2025-06-13: 3.0M2025-06-30: 2.9M2025-07-15: 2.9M2025-07-31: 2.5M2025-08-15: 3.3M2025-08-29: 3.0M2025-09-15: 3.3M2025-09-30: 3.6M2025-10-15: 3.8M2025-10-31: 3.7M2025-11-14: 3.9M2025-11-28: 3.9M2025-12-15: 4.5M2025-12-31: 4.7M2026-01-15: 4.8M2026-01-30: 4.6M2026-02-13: 4.5M2026-02-27: 5.2M2026-03-13: 6.4M2026-03-31: 6.8M
    the 31 Mar 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Mar 2026Short interest and volume change

    had 6.4M shares sold short in the 13 Mar 2026 report, 1.7× the same report last year.

    Same report last year: 3.7M; its normal report is 3.5M.

    See the evidence
    This period
    6.4M (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    447K
    How far from its usual level
    +4.3
    Same report last year
    3.7M
    History used
    2,996 days
    2025-03-14: 3.7M2025-03-31: 3.4M2025-04-15: 3.4M2025-04-30: 3.5M2025-05-15: 3.2M2025-05-30: 2.7M2025-06-13: 3.0M2025-06-30: 2.9M2025-07-15: 2.9M2025-07-31: 2.5M2025-08-15: 3.3M2025-08-29: 3.0M2025-09-15: 3.3M2025-09-30: 3.6M2025-10-15: 3.8M2025-10-31: 3.7M2025-11-14: 3.9M2025-11-28: 3.9M2025-12-15: 4.5M2025-12-31: 4.7M2026-01-15: 4.8M2026-01-30: 4.6M2026-02-13: 4.5M2026-02-27: 5.2M2026-03-13: 6.4M
    the 13 Mar 2026 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 3 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 3 Mar 2026Filings record

    Director or officer change

  8. 4 Nov 2025Insiders record

    Cordani David (Chairman & CEO) bought 4,134 shares of CI ($999,932) (dated 3 Nov 2025)

  9. 20 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 20 Oct 2025Filings record

    Director or officer change

  11. 2 Jun 2025Filings record

    Director or officer change

  12. 15 May 2025Institutional holdings change

    saw 165 13F filers open a new position in the quarter ended 31 Mar 2025, 1.2× the same quarter last year.

    Same quarter last year: 143; its normal quarter is 104.

    See the evidence
    This period
    165 (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    104
    Typical spread (median absolute deviation)
    10
    How far from its usual level
    +4.1
    Same quarter last year
    143
    History used
    4,200 days
    2023-03-31: 1042023-06-30: 1022023-09-30: 912023-12-31: 1242024-03-31: 1432024-06-30: 1042024-09-30: 1112024-12-31: 762025-03-31: 165
    the quarter ended 31 Mar 20258 earlier quartersnormal: 104

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  13. 28 Apr 2025Filings record

    Director or officer change

  14. 28 Apr 2025Filings record

    A major agreement ended

  15. 18 Apr 2025Filings record

    Director or officer change

  16. 30 Mar 2025Lobbying record

    THE CIGNA GROUP AND SUBSIDIARIES: new lobbying registration (BELLWETHER GOVERNMENT AFFAIRS LLC) (dated 17 Mar 2025)

  17. 13 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 13 Mar 2025Filings record

    Director or officer change

  19. 13 Nov 2024Institutional holdings record

    GQG Partners LLC opened a $1.1B position (2024Q3 13F)

  20. 5 Nov 2024Financials change

    reported revenue of $63.7B for the quarter ended 30 Sep 2024, 1.3× the same quarter last year.

    Same quarter last year: $49.0B; its normal quarter is $48.8B.

    See the evidence
    This period
    $63.7B (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    $48.8B
    Typical spread (median absolute deviation)
    $2.7B
    How far from its usual level
    +3.0
    Same quarter last year
    $49.0B
    History used
    2,740 days
    2022-09-30: $45.3B2022-12-31: $45.8B2023-03-31: $46.5B2023-06-30: $48.6B2023-09-30: $49.0B2023-12-31: $51.1B2024-03-31: $57.3B2024-06-30: $60.5B2024-09-30: $63.7B
    the quarter ended 30 Sep 20248 earlier quartersnormal: $48.8B

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  21. 20 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 20 Jun 2024Filings record

    Director or officer change

  23. 10 Apr 2024Short interest and volume change

    had 5.6M shares sold short in the 28 Mar 2024 report, 1.8× the same report last year.

    Same report last year: 3.1M; its normal report is 3.2M.

    See the evidence
    This period
    5.6M (the 28 Mar 2024 report)
    Normal report (median of 24 earlier)
    3.2M
    Typical spread (median absolute deviation)
    261K
    How far from its usual level
    +6.2
    Same report last year
    3.1M
    History used
    2,281 days
    2023-03-31: 3.1M2023-04-14: 2.8M2023-04-28: 3.8M2023-05-15: 3.0M2023-05-31: 2.4M2023-06-15: 3.1M2023-06-30: 3.3M2023-07-14: 3.1M2023-07-31: 2.6M2023-08-15: 3.1M2023-08-31: 2.7M2023-09-15: 3.2M2023-09-29: 2.8M2023-10-13: 3.3M2023-10-31: 3.4M2023-11-15: 3.4M2023-11-30: 2.7M2023-12-15: 3.4M2023-12-29: 3.8M2024-01-12: 3.5M2024-01-31: 3.1M2024-02-15: 7.3M2024-02-29: 6.5M2024-03-15: 5.8M2024-03-28: 5.6M
    the 28 Mar 2024 report24 earlier reportsnormal: 3.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 27 Mar 2024Short interest and volume change

    had 5.8M shares sold short in the 15 Mar 2024 report, 2.1× the same report last year.

    Same report last year: 2.8M; its normal report is 3.1M.

    See the evidence
    This period
    5.8M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    3.1M
    Typical spread (median absolute deviation)
    275K
    How far from its usual level
    +6.5
    Same report last year
    2.8M
    History used
    2,268 days
    2023-03-15: 2.8M2023-03-31: 3.1M2023-04-14: 2.8M2023-04-28: 3.8M2023-05-15: 3.0M2023-05-31: 2.4M2023-06-15: 3.1M2023-06-30: 3.3M2023-07-14: 3.1M2023-07-31: 2.6M2023-08-15: 3.1M2023-08-31: 2.7M2023-09-15: 3.2M2023-09-29: 2.8M2023-10-13: 3.3M2023-10-31: 3.4M2023-11-15: 3.4M2023-11-30: 2.7M2023-12-15: 3.4M2023-12-29: 3.8M2024-01-12: 3.5M2024-01-31: 3.1M2024-02-15: 7.3M2024-02-29: 6.5M2024-03-15: 5.8M
    the 15 Mar 2024 report24 earlier reportsnormal: 3.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 12 Mar 2024Short interest and volume change

    had 6.5M shares sold short in the 29 Feb 2024 report, 2.4× the same report last year.

    Same report last year: 2.7M; its normal report is 3.1M.

    See the evidence
    This period
    6.5M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    3.1M
    Typical spread (median absolute deviation)
    282K
    How far from its usual level
    +8.0
    Same report last year
    2.7M
    History used
    2,253 days
    2023-02-28: 2.7M2023-03-15: 2.8M2023-03-31: 3.1M2023-04-14: 2.8M2023-04-28: 3.8M2023-05-15: 3.0M2023-05-31: 2.4M2023-06-15: 3.1M2023-06-30: 3.3M2023-07-14: 3.1M2023-07-31: 2.6M2023-08-15: 3.1M2023-08-31: 2.7M2023-09-15: 3.2M2023-09-29: 2.8M2023-10-13: 3.3M2023-10-31: 3.4M2023-11-15: 3.4M2023-11-30: 2.7M2023-12-15: 3.4M2023-12-29: 3.8M2024-01-12: 3.5M2024-01-31: 3.1M2024-02-15: 7.3M2024-02-29: 6.5M
    the 29 Feb 2024 report24 earlier reportsnormal: 3.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 28 Feb 2024Short interest and volume change

    had 7.3M shares sold short in the 15 Feb 2024 report, 3.1× the same report last year.

    Same report last year: 2.3M; its normal report is 3.1M.

    See the evidence
    This period
    7.3M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    3.1M
    Typical spread (median absolute deviation)
    288K
    How far from its usual level
    +9.8
    Same report last year
    2.3M
    History used
    2,239 days
    2023-02-15: 2.3M2023-02-28: 2.7M2023-03-15: 2.8M2023-03-31: 3.1M2023-04-14: 2.8M2023-04-28: 3.8M2023-05-15: 3.0M2023-05-31: 2.4M2023-06-15: 3.1M2023-06-30: 3.3M2023-07-14: 3.1M2023-07-31: 2.6M2023-08-15: 3.1M2023-08-31: 2.7M2023-09-15: 3.2M2023-09-29: 2.8M2023-10-13: 3.3M2023-10-31: 3.4M2023-11-15: 3.4M2023-11-30: 2.7M2023-12-15: 3.4M2023-12-29: 3.8M2024-01-12: 3.5M2024-01-31: 3.1M2024-02-15: 7.3M
    the 15 Feb 2024 report24 earlier reportsnormal: 3.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 19 Jan 2024Filings record

    Director or officer change

  28. 17 Jan 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 17 Jan 2024Filings record

    Director or officer change

  30. 8 Nov 2023Institutional holdings record

    PARNASSUS INVESTMENTS, LLC opened a $731.0M position (2023Q3 13F)

  31. 15 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 15 Sep 2023Filings record

    Director or officer change

  33. 20 Jul 2023Lobbying record

    CIGNA CORPORATION: lobbying engagement terminated (THE NICKLES GROUP, LLC) (dated 30 Jun 2023)

  34. 17 Jul 2023Lobbying record

    THE CIGNA GROUP AND SUBSIDIARIES: new lobbying registration (ATLAS CROSSING LLC) (dated 16 Jun 2023)

  35. 1 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 1 May 2023Filings record

    Director or officer change

  37. 13 Feb 2023Institutional holdings record

    GQG Partners LLC opened a $797.0M position (2022Q4 13F)

  38. 10 Aug 2022Short interest and volume change

    had 6.9M shares sold short in the 29 Jul 2022 report, 1.8× the same report last year.

    Same report last year: 3.7M; its normal report is 3.8M.

    See the evidence
    This period
    6.9M (the 29 Jul 2022 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    506K
    How far from its usual level
    +4.1
    Same report last year
    3.7M
    History used
    1,673 days
    2021-07-15: 3.7M2021-07-30: 3.7M2021-08-13: 4.3M2021-08-31: 10.0M2021-09-15: 8.9M2021-09-30: 6.5M2021-10-15: 4.8M2021-10-29: 4.2M2021-11-15: 3.9M2021-11-30: 5.0M2021-12-15: 4.7M2022-01-14: 4.0M2022-01-31: 3.2M2022-02-15: 3.3M2022-02-28: 3.4M2022-03-15: 4.2M2022-03-31: 3.5M2022-04-14: 3.4M2022-04-29: 3.2M2022-05-13: 3.0M2022-05-31: 2.5M2022-06-15: 3.6M2022-06-30: 3.8M2022-07-15: 7.9M2022-07-29: 6.9M
    the 29 Jul 2022 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 27 Jul 2022Short interest and volume change

    had 7.9M shares sold short in the 15 Jul 2022 report, 2.1× the same report last year.

    Same report last year: 3.7M; its normal report is 3.8M.

    See the evidence
    This period
    7.9M (the 15 Jul 2022 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    506K
    How far from its usual level
    +5.4
    Same report last year
    3.7M
    History used
    1,659 days
    2021-06-30: 4.5M2021-07-15: 3.7M2021-07-30: 3.7M2021-08-13: 4.3M2021-08-31: 10.0M2021-09-15: 8.9M2021-09-30: 6.5M2021-10-15: 4.8M2021-10-29: 4.2M2021-11-15: 3.9M2021-11-30: 5.0M2021-12-15: 4.7M2022-01-14: 4.0M2022-01-31: 3.2M2022-02-15: 3.3M2022-02-28: 3.4M2022-03-15: 4.2M2022-03-31: 3.5M2022-04-14: 3.4M2022-04-29: 3.2M2022-05-13: 3.0M2022-05-31: 2.5M2022-06-15: 3.6M2022-06-30: 3.8M2022-07-15: 7.9M
    the 15 Jul 2022 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 25 Sep 2021Short interest and volume change

    had 8.9M shares sold short in the 15 Sep 2021 report, 2.5× the same report last year.

    Same report last year: 3.6M; its normal report is 4.3M.

    See the evidence
    This period
    8.9M (the 15 Sep 2021 report)
    Normal report (median of 24 earlier)
    4.3M
    Typical spread (median absolute deviation)
    624K
    How far from its usual level
    +4.9
    Same report last year
    3.6M
    History used
    1,356 days
    2020-09-15: 3.6M2020-09-30: 3.7M2020-10-15: 3.6M2020-10-30: 3.7M2020-11-13: 3.7M2020-11-30: 3.6M2020-12-15: 3.6M2020-12-31: 3.6M2021-01-15: 4.4M2021-01-29: 4.5M2021-02-12: 4.4M2021-02-26: 4.9M2021-03-15: 4.7M2021-03-31: 4.5M2021-04-15: 4.7M2021-04-30: 5.1M2021-05-14: 5.6M2021-05-28: 5.2M2021-06-15: 4.2M2021-06-30: 4.5M2021-07-15: 3.7M2021-07-30: 3.7M2021-08-13: 4.3M2021-08-31: 10.0M2021-09-15: 8.9M
    the 15 Sep 2021 report24 earlier reportsnormal: 4.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 150 entries; narrow the window or the kind of data to see older ones.

Not listed: 235 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001739940
Ticker
CI
Domain
thecignagroup.com
Employer name
cigna health and life insurance, eviCore Healthcare MSI LLC, express scripts administrators (3 unverified)
Fein
62-1615395 (1 unverified)
Hq location
CT|BLOOMFIELD|06002 (1 unverified)
Lobbying client
cigna, cigna corporation and subsidiaries, cigna group, cigna group and subsidiaries and 2 more
Name
2025 Subsidiaries Or Affiliates, Accredo Health, Incorporated, Allegiance Life & Health Insurance Company, Care Alliance of Florida, LLC and 69 more
Wikidata
Q642271
Wikipedia
The Cigna Group
  • DOL H-1B labor condition applications and PERM certifications853 data points7 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)88 records, 279 data points30 Dec 1950 to 30 Sep 2026
  • SEC Form 13F institutional holdings9 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)120 records21 Sep 2018 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)571 data points31 Dec 2015 to 30 Oct 2026
  • SEC Form 4 insider transactions144 records, 396 data points11 Feb 2019 to 8 Sep 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • WARN layoff notices (state labor agencies)1 record, 3 data points27 Feb 2017 to 1 Mar 2017
  • Wikipedia pageviews915 data points30 Jul 2023 to 21 Nov 2026